Posted By: HGG Advances HGGA: What motivated you to start working on this project? TS: As RNA-seq is now the state-of-the-art method for measuring gene expression, we were motivated to help researchers better design these experiments for eQTL mapping, a common application using RNA-seq data. We found that it’s possible to boost association power by... Read More
Posted By: HGG Advances HGGA: What motivated you to start working on this project? AB: Clinical manifestations among C. trachomatis patients are highly variable. For example, up to 80% of C. trachomatis genital infections are asymptomatic and if left untreated, can lead to severe clinical outcomes such as pelvic inflammatory disease, ectopic pregnancies, and infertility.... Read More
Posted By: HGG Advances HGGA: What motivated you to start working on this project? NU: Despite being first described over 100 years ago, mutations underlying hepatic hemangiomas (HHs) had not been identified. Mutations associated with cutaneous venous malformations (CVMs) have been found, but a significant proportion still have no genetic explanation. We also found it... Read More
ASHG uses cookies to provide you with a secure and custom web experience. Privacy Policy